These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25899758)

  • 21. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
    Kamiya H; Himeno T; Watarai A; Baba M; Nishimura R; Tajima N; Nakamura J
    J Diabetes Investig; 2024 Feb; 15(2):247-253. PubMed ID: 38213265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations.
    Haque F; Ibne Reaz MB; Chowdhury MEH; Md Ali SH; Ashrif A Bakar A; Rahman T; Kobashi S; Dhawale CA; Sobhan Bhuiyan MA
    Comput Biol Med; 2021 Dec; 139():104954. PubMed ID: 34715551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.
    Sloan G; Selvarajah D; Tesfaye S
    Nat Rev Endocrinol; 2021 Jul; 17(7):400-420. PubMed ID: 34050323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic neuropathies.
    Wein TH; Albers JW
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):307-20, ix. PubMed ID: 11345009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Heier M; Püttgen S; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Care; 2017 Apr; 40(4):569-576. PubMed ID: 28174259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographic and Clinical Factors Associated with Depression in 140 Hospitalized Diabetic Patients with Distal Symmetric Polyneuropathy Evaluated Using Beck Depression Inventory and 6-Item Neuropathy Total Symptom Score Questionnaire.
    Dziemidok P; Gorczyca-Siudak D; Makara-Studzińska M
    Med Sci Monit; 2023 Mar; 29():e939043. PubMed ID: 36860122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy.
    Kasznicki J
    Arch Med Sci; 2014 May; 10(2):345-54. PubMed ID: 24904671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and diagnostic features of small fiber damage in diabetic polyneuropathy.
    Javed S; Petropoulos IN; Tavakoli M; Malik RA
    Handb Clin Neurol; 2014; 126():275-90. PubMed ID: 25410229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of diabetic polyneuropathy: Update 2006.
    Ziegler D
    Ann N Y Acad Sci; 2006 Nov; 1084():250-66. PubMed ID: 17151306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensory Phenotypes Provide Insight Into the Natural Course of Diabetic Polyneuropathy.
    Tsilingiris D; Schimpfle L; von Rauchhaupt E; Sulaj A; Seebauer L; Herzig S; Szendroedi J; Kopf S; Κender Ζ
    Diabetes; 2024 Jan; 73(1):135-146. PubMed ID: 37862374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic Neuropathy in Hands: An Endemic Complication Waiting to Unfold?
    Sierra-Silvestre E; Andrade RJ; Schroeter AC; Bisset L; Coppieters MW
    Diabetes; 2022 Aug; 71(8):1785-1794. PubMed ID: 35622081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus.
    Chang KH; Chen CM; Lin CN; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Weng YC; Hwang JS; Kuo HC
    J Peripher Nerv Syst; 2023 Dec; 28(4):651-663. PubMed ID: 37831393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.
    Ziegler D; Strom A; Bönhof GJ; Kannenberg JM; Heier M; Rathmann W; Peters A; Meisinger C; Roden M; Thorand B; Herder C
    BMJ Open Diabetes Res Care; 2019; 7(1):e000752. PubMed ID: 31803481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic polyneuropathy. Risk factors, patterns of presentation, diagnosis, and treatment.
    Poncelet AN
    Geriatrics; 2003 Jun; 58(6):16-8, 24-5, 30. PubMed ID: 12813869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic Neuropathies.
    Elafros MA; Callaghan BC
    Continuum (Minneap Minn); 2023 Oct; 29(5):1401-1417. PubMed ID: 37851036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New diagnostic tests for diabetic distal symmetric polyneuropathy.
    Papanas N; Ziegler D
    J Diabetes Complications; 2011; 25(1):44-51. PubMed ID: 19896871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of polyneuropathy in diabetes and prediabetes.
    Ziegler D; Papanas N; Vinik AI; Shaw JE
    Handb Clin Neurol; 2014; 126():3-22. PubMed ID: 25410210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetes mellitus and autoimmune neuropathy].
    Deguchi T; Nishio Y; Takashima H
    Brain Nerve; 2014 Feb; 66(2):135-47. PubMed ID: 24523312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From treatment to preventive actions: improving function in patients with diabetic polyneuropathy.
    Sacco IC; Sartor CD
    Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():206-12. PubMed ID: 26452065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic peripheral neuropathy and the management of diabetic peripheral neuropathic pain.
    Morales-Vidal S; Morgan C; McCoyd M; Hornik A
    Postgrad Med; 2012 Jul; 124(4):145-53. PubMed ID: 22913903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.